| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000034127 |
| Receipt No. | R000038890 |
| Scientific Title | Observational study on health condition of patients with ulcerative colitis |
| Date of disclosure of the study information | 2018/09/13 |
| Last modified on | 2021/09/16 (Ver. 7) |
| Basic information | ||
| Public title | Observational study on health condition of patients with ulcerative colitis | |
| Acronym | Observational study on health condition of patients with ulcerative colitis | |
| Scientific Title | Observational study on health condition of patients with ulcerative colitis | |
| Scientific Title:Acronym | Observational study on health condition of patients with ulcerative colitis | |
| Region |
|
|
| Condition | ||
| Condition | ulcerative colitis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Observe the clinical course of patients with ulcerative colitis and investigate the factors involved in the occurrence of events such as hospitalization and surgery. |
| Basic objectives2 | Others |
| Basic objectives -Others | Observe the clinical course of patients with ulcerative colitis and investigate the factors involved in the occurrence of events such as hospitalization and surgery. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Cumulative non-emergency hospitalization rate |
| Key secondary outcomes | Cumulative non-operation rate
Comparison of disease activity and endoscopic activity in groups with and without events (emergency hospitalization, surgery) Comparison of the expression of inflammatory cytokines in the group with and without events Comparison of lymphocyte subsets of events with and without events Comparison of microbiota of the group with and without event Comparison of drug concentrations and anti-drug antibody with and without events |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who diagnosed with ulcerative colitis.
Patients who have received adequate information regarding this study and submitted written consent forms to this study. |
|||
| Key exclusion criteria | Patients who have a history of psychosomatic disorders.
Patients judged as inappropriate for the study because of their conditions. |
|||
| Target sample size | 160 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nagoya university hospital | ||||||
| Division name | Department of Gastroenterology and Hepatology | ||||||
| Zip code | 4668650 | ||||||
| Address | 65,Tsurumai-cho,Showa-ku,Nagoya city,Aichi prefecture | ||||||
| TEL | 052-741-2172 | ||||||
| makamura@med.nagoya-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nagoya university Graduate School of Medicine | ||||||
| Division name | Department of Gastroenterology and Hepatology | ||||||
| Zip code | 4668650 | ||||||
| Address | 65,Tsurumai-cho,Showa-ku,Nagoya city,Aichi prefecture | ||||||
| TEL | 052-741-2172 | ||||||
| Homepage URL | |||||||
| km1219@med.nagoya-u.ac.jp | |||||||
| Sponsor | |
| Institute | Nagoya university Graduate School of Medicine
Department of Gastroenterology and Hepatology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Institutional Review Board of Nagoya university |
| Address | 65,Tsurumai-cho,Showa-ku,Nagoya city,Aichi prefecture |
| Tel | 052-744-2973 |
| ethics@med.nagoya-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | None |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000038890 |